Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STIM1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | CLDN24 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | MGAT2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | NUCKS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ADGRE2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ADORA2A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | KLF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | DCP1A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | CDK8 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | TTLL4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |